SM
AZN icon

Sabby Management’s AstraZeneca AZN Stock Holding History

Sabby Management’s Portfolio AZN Stock Details AZN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q1 		– Sell
-1,746
Closed -$17.5M – 164
2020
Q4 		$17.5M Buy
1,746
+208
+14% +$22K 3.35% 10
2020
Q3 		$16.9M Buy
1,538
+1,200
+355% +$133K 2.52% 11
2020
Q2 		$3.57M Buy
+338
New +$34.9K 0.72% 24
2019
Q1 		– Sell
-1,656
Closed -$12.6M – 89
2018
Q4 		$12.6M Sell
1,656
-147
-8% -$11.5K 2.77% 9
2018
Q3 		$14.3M Buy
1,803
+120
+7% +$9.08K 1.83% 15
2018
Q2 		$11.8M Sell
1,683
-2,507
-60% -$180K 1.83% 15
2018
Q1 		$29.3M Buy
4,190
+434
+12% +$30.1K 3.49% 8
2017
Q4 		$26.1M Buy
3,756
+2,734
+268% +$184K 2.37% 9
2017
Q3 		$6.92M Sell
1,022
-891
-47% -$56.3K 0.45% 30
2017
Q2 		$13M Sell
1,913
-206
-10% -$13.5K 0.85% 19
2017
Q1 		$13.2M Buy
+2,119
New +$123K 0.71% 24
2015
Q1 		– Sell
-4,338
Closed -$30.5K – 297
2014
Q4 		$30.5K Sell
4,338
-301
-6% -$21.6K 0.96% 17
2014
Q3 		$40.4K Buy
4,639
+3,647
+368% +$267K 1.55% 13
2014
Q2 		$7.37M Buy
+992
New +$71.7K 0.32% 46
2013
Q4 		– Sell
-2,060
Closed -$10.7M – 223
2013
Q3 		$10.7M Buy
+2,060
New +$103K 0.7% 38

Other funds holding AZN

T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return
Fisher Asset Management
Fisher Asset Management Camas, Washington $295B AUM 31.6% 1-Year Est. Return
GQG Partners
GQG Partners Ft. Lauderdale, Florida $63.1B AUM 23.07% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

Sabby Management's AZN Position: Q1 2021 in Review

Sabby Management sold out of AstraZeneca (AZN) in Q1 2021, closing a stake of 182,500 shares — an estimated $18.2M sold.

Sabby Management first reported a position in AZN in Q3 2013 and held it in 8 quarters. The position peaked at $18.2M in Q4 2020. 756 funds tracked by Wall St. Rank hold AZN as of Q1 2021.

  • Sabby Management reported no remaining AstraZeneca position as of Q1 2021 after selling out during the quarter.
  • Sabby Management sold 182,500 AstraZeneca shares in Q1 2021, an estimated $18.2M.
  • Sabby Management first reported a position in AstraZeneca in Q3 2013 and held it in 8 quarters.
  • Sabby Management's AstraZeneca position peaked at $18.2M in Q4 2020.
  • 756 funds tracked by Wall St. Rank held AstraZeneca as of Q1 2021.

Based on Sabby Management's 13F filing for Q1 2021, filed 17 May 2021.